Am. J. Trop. Med. Hyg., 77(6), 2007, pp. 1124-1127
Copyright © 2007 by The American Society of Tropical Medicine and Hygiene
CASE REPORT
Borrelia valaisiana Infection in a Japanese Man Associated with Traveling to Foreign Countries
Kan Saito,
Takafumi Ito,
Nobuko Asashima,
Minoru Ohno,
Ryozo Nagai,
Hiromi Fujita,
Nobuo Koizumi,
Ai Takano,
Haruo Watanabe, AND
Hiroki Kawabata*
Department of Cardiovascular Medicine, and Department of Dermatology, University of Tokyo Graduate School of Medicine, Tokyo, Japan; Ohara Research Laboratory, Ohara General Hospital, Fukushima, Japan; Department of Bacteriology, National Institute of Infectious Diseases, Tokyo, Japan; Doctoral Course of the United Graduate School of Veterinary Sciences, Gifu University, National University Corporation, Gifu, Japan
ABSTRACT
A 78-year-old Japanese man who had clinical symptoms and a flu-like illness with fever, chills, diarrhea, and arthralgia had traveled to Cambodia and Khabarovsk, Russia, before the onset of symptoms and illness. He had been bitten by an Ixodes persulcatus tick in which the DNA of Borrelia valaisiana was detected. The patients symptoms improved rapidly after treatment with minocycline. Serologic examination detected antibodies to Lyme disease Borrelia. An flaB polymerase chain reaction with the patients plasma amplified a DNA fragment similar to that of B. valaisiana.
Lyme borreliosis1 is the most prevalent tick-borne zoonotic disease in Europe, North America, and the Far Eastern countries.2,3 Spirochetes belonging to the Lyme disease group are classified into 12 species. Borrelia burgdorferi4 is found in North America and Europe and is pathogenic to humans; B. garinii5 and B. afzelii6 are found in Europe and east Asian countries and are pathogenic to humans7; B. valaisiana,8,9 B. lusitaniae,10 and B. spielmanii11,12 are found in Ixodes ricinus in Europe7; B. japonica, B. tanukii, and B. turdi are found in I. ovatus, I. tanuki, and I. turdus, respectively, in Japan13,14; B. andersonii is found in I. dentatus15; B. bissettii16 is found in I. spinipalpis in North America; and B. sinica is found in I. ovatus in China.17
The geographic distribution and enzootic transmission cycles of Borrelia species isolated in Japan have been well characterized. Borrelia garinii and B. afzelii are transmitted by I. persulcatus in Hokkaido and the northern half of Honshu,18–21 and B. japonica is transmitted by I. ovatus in Hokkaido and most of Honshu.22,23 The Japanese strain Am501, which was isolated from the rare tick species I. columnae,24 has been identified as the B. valaisiana strain most commonly found in Europe.8
Takada and others reported B. valaisiana in Mus calori captured in the southernmost island of Japan, Okinawa, which is located in the subtropical zone.25 B. valaisiana was previously found in I. nipponensis in the Republic of Korea,26 in small wild mammals captured in Taiwan,27 and in small wild mammals and I. granulatus captured in China.17 Recently, B. valaisiana, which is widely distributed in the Far Eastern countries, was found in Japan.28 In the present report, we describe, to our knowledge, the first Japanese case of human infection with B. valaisiana.
On June 24, 2005, a 78-year-old Japanese man who had been treated for respiratory and heart disease was admitted to Tokyo University Hospital with febricity, fatigue, poor appetite, and cough. The patient had visited Cambodia from May 27 to June 7, 2005, and then had gone to Khabarovsk, Russia from June 10 to June 13, 2005, to hunt butterflies. He complained of a flu-like illness with fever, chills, diarrhea and arthralgia, but without swollen joints or erythema migrans. Hematologic examination showed a leukocyte count of 5,500/µL and a C-reactive protein (CRP) level of 4.48 mg/dL (normal < 0.5 mg/dL) on June 24. No abnormal results were found in other blood examinations. Although Cefotiam (2 g/day) was administered beginning on June 27, the patients condition did not improve, and the CRP level increased from 4.48 mg/dL to 9.83 mg/dL. A black tumor-like wart 10 mm in diameter was found at the right auricle in a subsequent medical examination and was recognized as a tick body by a dermatologist. Antibiotic treatment was changed from cefotiam to minocycline (200 mg/day) on June 30 because of the suspicion of Borrelia infection. Minocycline was continued until July 11. The patients symptoms improved rapidly and he left the hospital on July 12.
Blood (
7 mL) and the tick body were collected on July 6, 2005 for serodiagnosis, bacterial cultivation, and polymerase chain reaction (PCR) examination. Serologic examination by immunoblotting20 was performed to detect antibodies to B. burgdorferi (strain B31), B. garinii (strain HP1 isolated from I. persulcatus in Hokkaido, Japan), and B. afzelii (strain P/Gau isolated from cerebrospinal fluid in Germany). Results for IgG against B. garinii were positive according to Centers for Disease Control and Prevention criteria.29 The IgM reacted strongly with 41-kD antigen (flagellin) of the Borrelia strains used for examination (Figure 1
). To confirm seroreactivity, recomBlot BorreliaNB IgM (Mikrogen, Martinsried, Germany) was used. A recombinant 39-kD antigen reacted with the patients serum. The 39-kD antigen did not react under conventional immunoblotting methods with whole bacterial cells, which suggested that results were positive for IgM.29 Although it is recommended to test convalescent-phase serum samples, we were unable to carry out this test because the patient did not return to the hospital. Results of tests for antibodies to other arthropod-borne pathogens such as Francisella tularensis, Brucella abortus, Rickettsia japonica (the infectious agent of spotted fever rickettsiosis), Rickettsia typhi (the infectious agent of murine typhus rickettsiosis), and Coxella burnetii were negative.

View larger version (78K):
[in this window]
[in a new window]
|
FIGURE 1. Immunoblotting patterns of IgM and IgM specific for Borrelia species in serum from the patient. Molecular mass markers are shown on the left in kilodaltons (kDa). A convalescent-phase serum sample from a patient with Lyme disease (Lyme disease convalescent) was used as a positive control.
|
|
Isolation of Borrelia from the whole blood was performed by inoculation into 10 mL of antibiotic-free Barbour-Stoenner-Kelly medium, which was prepared as described.30 The cultures were incubated at 33°C for 3 months; however, no spirochetes grew during the incubation period.
For PCR amplification, DNA was extracted from the patients blood and the tick body. Plasma and blood cells were obtained from 6 mL of EDTA-treated blood by centrifugation at 280 x g for 10 minutes).31 Plasma was centrifuged at 15,000 x g, and the pellet was used to for isolation of DNA. Extraction of DNA from the sample was performed by using a High Pure PCR Template Purification Kit (Roche Diagnostics, Basel, Switzerland) following the manufacturers instructions. The DNA from the silica matrix was eluted with 100 µL of sterile water, and the eluted DNA solution was reduced into 20 µL by ethanol precipitation.32 Five microliters of the DNA solution was used for the PCR.
DNA extraction from the tick body was carried out by freezing the engorged tick body with liquid nitrogen and crushing. The DNA was extracted from the crushed tick body as described.33 To detect Borrelia DNA, we performed a nested flaB-PCR and an rrf-rrl intergenic spacer (RIS)–PCR,34,35 which identified Borrelia flaB-DNA and RIS-DNA fragments in the tick.
The patients plasma was positive for Borrelia by nested flaB-PCR, but negative by RIS-PCR. Amplified DNAs from tick and plasma were purified with a High Pure PCR Product Purification Kit (Roche Diagnostics), and sequencing was performed as described.32 The flaB sequence of the sample showed a high similarity value (98.6–97.4%) to that of B. valaisiana previously isolated in Far East countries and 96.0% DNA identity with B. valaisiana strain VS116 (GenBank accession no. D82854) (Table 1
). It was experimentally confirmed that Lyme disease spirochetes were transiently present in the blood of the patient at a low density.36 In this study, the result of the nested flaB-PCR were positive but those of the RIS-PCR were negative, which may be explained by the experimental result that Lyme disease spirochetes were transiently present in the blood of the patient at a low density. This finding may also cause a false-negative result when the patients blood is examined by PCR.
View this table:
[in this window]
[in a new window]
|
TABLE 1 DNA identities in the flaB sequence of Borrelia detected in the present study compared with representative strains
|
|
To identify the tick species collected from the patient, we determined a partial sequence of the mitochondrial 16S ribosomal RNA gene (mt-rrs) of the tick and compared it with sequences in Genbank/European Molecular Biology Laboratory/DNA Data Bank of Japan because of its usefulness in tick species identification.37 The oligonucleotide primers 5'-CTGCTCAATGATTTTTTAAATTGCTGTGG-3' and 5'-CCGGTCTGAACTCAGATCAAGTA-3' were used for amplification of the DNA fragment of mt-rrs, and sequencing of amplified products was carried out as described.38 The mt-rrs sequence of the tick was aligned with data deposited in Genbank/European Molecular Biology Laboratory/DNA Data Bank of Japan GenBank and the similarity value (%) was calculated. The DNA sequence of the tick showed a high similarity to that of I. persulcatus (99.2–100%), and other Ixodes ticks showed a similarity < 93.5% (Table 2
). On the basis of these results, the tick was identified as I. persulcatus.
View this table:
[in this window]
[in a new window]
|
TABLE 2 Comparison of the identity of the mt-rrs sequence of the tick in the present study with known sequences of representative Ixodes ticks
|
|
We assume that the patient received the tick bite that caused Lyme disease by infection with B. valaisiana species in Khabarovsk, Russia, because he had no history of visiting tick habitat areas in Japan before the onset of the disease, and because I. persulcatus has been documented in Khabarovsk but not in Cambodia.21 Borrelia valaisiana has been reported in the southeastern regions of Asia, such as southern China, Taiwan, the southern tip of the Korean Peninsula, and the Okinawa Islands in Japan.28 Our observations suggest that B. valaisiana is present in Russia, although, to the best of our knowledge, B. valaisiana has not been isolated in Khabarovsk.21,28,39 Thus, we do not rule out the possibility that the patient was infected in Cambodia or some other area and was later bitten by I. persulcatus in Khabarovsk.
To our knowledge, this is the first case report of human infection with B. valaisiana in Japan. It has been reported that the Borrelia species are widely distributed in countries in the Far East.28 On the basis of the present study, it is strongly recommended that people should take precautions against tick bites not only in regions where Lyme disease is endemic, but also in southeast Asia and other areas where ticks are infected with B. valaisiana.
Received May 8, 2006.
Accepted for publication July 19, 2007.
Acknowledgments: We thank Toshiyuki Masuzawa (Chiba Institute of Sciences) and Noburiro Takada (Fukui University) for helpful discussions.
Financial support: This work was supported in part by a grant for research on emerging and reemerging infectious diseases from the Japanese Ministry of Health, Labor and Welfare.
* Address correspondence to Hiroki Kawabata, Department of Bacteriology, National Institute of Infectious Diseases, Toyama 1-23-1, Shinjuku, Tokyo 162-8640, Japan. E-mail: kbata{at}nih.go.jp 
Authors addresses: Kan Saito, Takafumi Ito, Minoru Ohno, and Ryozo Nagai, Department of Cardiovascular Medicine, University of Tokyo Graduate School of Medicine, Hongo 7-3-1, Bunkyo-ku, Tokyo 113-8655, Japan. Nobuko Asashima, Department of Dermatology, University of Tokyo Graduate School of Medicine, Hongo 7-3-1, Bunkyo-ku, 113-8655 Tokyo, Japan. Hiromi Fujita, Ohara Research Laboratory, Ohara General Hospital, Kamata-Nakae 33, Fukushima, Fukushima 960-0195 Japan. Nobuo Koizumi and Hiroki Kawabata, Department of Bacteriology, National Institute of Infectious Diseases, Toyama 1-23-1, Shinjuku-ku, Tokyo 162-8640, Japan. Ai Takano and Haruo Watanabe, Department of Bacteriology, National Institute of Infectious Diseases, Toyama 1-23-1, Shinjuku-ku, Tokyo 162-8640, Japan and Doctoral Course of the United Graduate School of Veterinary Sciences, Yanagido 1-1, Gifu University, National University Corporation, Gifu 501-1193, Japan.
REFERENCES
- Burgdorfer W, Barbour AG, Hayes SF, Benach JL, Grunwaldt E, Davis JP, 1982. Lyme disease – a tick-borne spirochetosis? Science 216: 1317–1319.[Abstract/Free Full Text]
- Steere AC, 2001. Lyme disease. N Engl J Med 34: 115–125.
- Yanagihara Y, Masuzawa T, 1997. Lyme disease (Lyme borreliosis). FEMS Immunol Med Microbiol 18: 249–261.[Web of Science][Medline]
- Johnson RC, Schmid GP, Hyde FW, Steingerwalt AG, Brenner DJ, 1984. Borrelia burgdorferi sp. nov., etiologic agent of Lyme disease. Int J Syst Bacteriol 34: 496–497.[Abstract/Free Full Text]
- Baranton G, Postic D, Saint Girons I, Boerlin P, Piffaretti JC, Assous M, Grimont PA, 1992. Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp. nov., and group VS461 associated with Lyme borreliosis. Int J Syst Bacteriol 42: 378–383.[Abstract/Free Full Text]
- Canica MM, Nato F, du Merle L, Mazie JC, Baranton G, Postic D, 1993. Monoclonal antibodies for identification of Borrelia afzelii sp. nov. associated with late cutaneous manifestations of Lyme borreliosis. Scand J Infect Dis 25: 441–448.[Web of Science][Medline]
- Wang G, van Dam AP, Schwartz I, Dankert J, 1999. Molecular typing of Borrelia burgdorferi sensu lato: taxonomic, epidemiological, and clinical implications. Clin Microbiol Rev 12: 633–653.[Abstract/Free Full Text]
- Wang G, van Dam AP, Dankert J, 1999. Evidence for frequent OspC gene transfer between Borrelia valaisiana sp. nov. and other Lyme disease spirochetes. FEMS Microbiol Lett 177: 289–296.[Web of Science][Medline]
- Diza E, Papa A, Vezyri E, Tsounis S, Milonas I, Antoniadis A, 2004. Borrelia valaisiana in cerebrospinal fluid. Emerg Infect Dis 10: 1692–1693.[Web of Science][Medline]
- Le Fleche A, Postic D, Girardet K, Peter O, Baranton G, 1997. Characterization of Borrelia lusitaniae sp. nov. by 16S ribosomal DNA sequence analysis. Int J Syst Bacteriol 47: 921–925.[Abstract/Free Full Text]
- Richter D, Schlee DB, Allgower R, Matuschka FR, 2004. Relationships of a novel Lyme disease spirochete, Borrelia spielmani sp. nov., with its hosts in central Europe. Appl Environ Microbiol 70: 6414–6419.[Abstract/Free Full Text]
- Foldvari G, Farkas R, Lakos A, 2005. Borrelia spielmanii erythema migrans, Hungary. Emerg Infect Dis 11: 1794–1795.[Web of Science][Medline]
- Kawabata H, Masuzawa T, Yanagihara Y, 1993. Genomic analysis of Borrelia japonica sp. nov. isolated from Ixodes ovatus in Japan. Microbiol Immunol 37: 843–848.[Web of Science][Medline]
- Fukunaga M, Hamase A, Okada K, Nakao M, 1996. Borrelia tanukii sp. nov. and Borrelia turdae sp. nov. found from ixodid ticks in Japan: rapid species identification by 16S rRNA gene-targeted PCR analysis. Microbiol Immunol 40: 877–881.[Web of Science][Medline]
- Marconi RT, Liveris D, Schwartz I, 1995. Identification of novel insertion elements, restriction fragment length polymorphism patterns, and discontinuous 23S rRNA in Lyme disease spirochetes: phylogenetic analyses of rRNA genes and their intergenic spacers in Borrelia japonica sp. nov. and genomic group 21038 (Borrelia andersonii sp. nov.) isolates. J Clin Microbiol 33: 2427–2434.[Abstract/Free Full Text]
- Postic D, Ras NM, Lane RS, Hendson M, Baranton G, 1998. Expanded diversity among Californian borrelia isolates and description of Borrelia bissettii sp. nov. (formerly Borrelia group DN127). J Clin Microbiol 36: 3497–3504.[Abstract/Free Full Text]
- Masuzawa T, Takada N, Kudeken M, Fukui T, Yano Y, Ishiguro F, Kawamura Y, Imai Y, Ezaki T, 2001. Borrelia sinica sp. nov., a Lyme disease-related Borrelia species isolated in China. Int J Syst Evol Microbiol 51: 1817–1824.[Abstract]
- Nakao M, Miyamoto K, Fukunaga M, Hashimoto Y, Takahashi H, 1994. Comparative studies on Borrelia afzelii isolated from a patient of Lyme disease, Ixodes persulcatus ticks, and Apodemus speciosus rodents in Japan. Microbiol Immunol 38: 413–420.[Web of Science][Medline]
- Nakao M, Miyamoto K, Fukunaga M, 1994. Lyme disease spirochetes in Japan: enzootic transmission cycles in birds, rodents, and Ixodes persulcatus ticks. J Infect Dis 170: 878–882.[Web of Science][Medline]
- Masuzawa T, Okada Y, Yanagihara Y, Sato N, 1991. Antigenic properties of Borrelia burgdorferi isolated from Ixodes ovatus and Ixodes persulcatus in Hokkaido, Japan. J Clin Microbiol 29: 1568–1573.[Abstract/Free Full Text]
- Masuzawa T, 2004. Terrestrial distribution of the Lyme borreliosis agent Borrelia burgdorferi sensu lato in east Asia. Jpn J Infect Dis 57: 229–235.[Medline]
- Nakao M, Miyamoto K, Fukunaga M, 1994. Borrelia japonica in nature: genotypic identification of spirochetes isolated from Japanese small mammals. Microbiol Immunol 38: 805–808.[Web of Science][Medline]
- Masuzawa T, Suzuki H, Kawabata H, Ishiguro F, Takada N, Yano Y, Yanagihara Y, 1995. Identification of spirochetes isolated from wild rodents in Japan as Borrelia japonica. J Clin Microbiol 33: 1392–1394.[Abstract/Free Full Text]
- Fukunaga M, Hamase A, Okada K, Inoue H, Tsuruta Y, Miyamoto K, Nakao M, 1996. Characterization of spirochetes isolated from ticks (Ixodes tanuki, Ixodes turdus, and Ixodes columnae) and comparison of the sequences with those of Borrelia burgdorferi sensu lato strains. Appl Environ Microbiol 62: 2338–2344.[Abstract/Free Full Text]
- Takada N, Fujita H, Yano Y, Ishiguro F, Iwasaki H, Masuzawa T, 2001. First records of tick-borne pathogens, Borrelia, and spotted fever group Rickettsiae in Okinawajima Island, Japan. Microbiol Immunol 45: 163–165.[Web of Science][Medline]
- Masuzawa T, Fukui T, Miyake M, Oh HB, Cho MK, Chang WH, Imai Y, Yanagihara Y, 1999. Determination of members of a Borrelia afzelii-related group isolated from Ixodes nipponensis in Korea as Borrelia valaisiana. Int J Syst Bacteriol 49: 1409–1415.[Abstract/Free Full Text]
- Masuzawa T, Pan MJ, Kadosaka T, Kudeken M, Takada N, Yano Y, Imai Y, Yanagihara Y, 2000. Characterization and identification of Borrelia isolates as Borrelia valaisiana in Taiwan and Kinmen Islands. Microbiol Immunol 44: 1003–1009.[Web of Science][Medline]
- Masuzawa T, Hashimoto N, Kudeken M, Kadosaka T, Nakamura M, Kawabata H, Koizumi N, Imai Y, 2004. New genomospecies related to Borrelia valaisiana, isolated from mammals in Okinawa archipelago, Japan. J Med Microbiol 53: 421–426.[Abstract/Free Full Text]
- Centers for Disease Control and Prevention, 1995. Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR Morb Mortal Wkly Rep 44: 590–591.[Medline]
- Barbour AG, 1984. Isolation and cultivation of Lyme disease spirochetes. Yale J Biol Med 57: 521–525.[Web of Science][Medline]
- Wormser GP, Bittker S, Cooper D, Nowakowski J, Nadelman RB, Pavia C, 2001. Yield of large - volume blood cultures in patients with early Lyme disease. J Infect Dis 184: 1070–1072.[Web of Science][Medline]
- Kawabata H, Dancel LA, Villanueva SY, Yanagihara Y, Koizumi N, Watanabe H, 2001. flaB-polymerase chain reaction (flaB-PCR) and its restriction fragment length polymorphism (RFLP) analysis are an efficient tool for detection and identification of Leptospira spp. Microbiol Immunol 45: 491–496.[Web of Science][Medline]
- Kawabata H, Ando S, Kishimoto T, Kurane I, Takano A, Nogami S, Fujita H, Tsurumi M, Nakamura N, Sato F, Takahashi M, Ushijima Y, Fukunaga M, Watanabe H, 2006. First detection of Rickettsia in soft-bodied ticks associated with seabird, Japan. Microbiol Immunol 50: 403–406.[Web of Science][Medline]
- Sato Y, Konishi T, Hashimoto Y, Takahashi H, Nakaya K, Fukunaga M, Nakao M, 1997. Rapid diagnosis of Lyme disease: flagellin gene-based nested polymerase chain reaction for identification of causative Borrelia species. Int J Infect Dis 2: 64–73.
- Postic D, Assous MV, Grimont PA, Baranton G, 1994. Diversity of Borrelia burgdorferi sensu lato evidenced by restriction fragment length polymorphism of rrf (5S)-rrl (23S) intergenic spacer amplicons. Int J Syst Bacteriol 44: 743–752.[Abstract/Free Full Text]
- Wang G, Ojaimi C, Wu H, Saksenberg V, Iyer R, Liveris D, McClain SA, Wormser GP, Schwartz I, 2002. Disease severity in a murine model of Lyme borreliosis is associated with the genotype of the infecting Borrelia burgdorferi sensu stricto strain. J Infect Dis 186: 782–791.[Web of Science][Medline]
- Norris DE, Klompen JS, Keirans JE, Black IV WC, 1996. Population genetics of Ixodes scapularis (Acari: Ixodidae) based on mitochondrial 16S and 12S genes. J Med Entomol 33: 78–89.[Web of Science][Medline]
- Ushijima Y, Oliver JH Jr, Keirans JE, Tsurumi M, Kawabata H, Watanabe H, Fukunaga M, 2003. Mitochondrial sequence variation in Carlos capensis (Neumann), a parasite of seabirds, collected on Torishima Island in Japan. J Parasitol 89: 196–198.[Medline]
- Sato Y, Miyamoto K, Iwaki A, Masuzawa T, Yanagihara Y, Korenberg EI, Gorelova NB, Volkov VI, Ivanov LI, Liberova RN, 1996. Prevalence of Lyme disease spirochetes in Ixodes persulcatus and wild rodents in far eastern Russia. Appl Environ Microbiol 62: 3887–3889.[Abstract/Free Full Text]
This article has been cited by other articles:

|
 |

|
 |
 
I. Krupka, J. Knauer, L. Lorentzen, T. P. O'Connor, J. Saucier, and R. K. Straubinger
Borrelia burgdorferi Sensu Lato Species in Europe Induce Diverse Immune Responses against C6 Peptides in Infected Mice
Clin. Vaccine Immunol.,
November 1, 2009;
16(11):
1546 - 1562.
[Abstract]
[Full Text]
[PDF]
|
 |
|